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Despite	past	Congressional	action	on	insider	trading,
Senators’	stock	trades	are	still	business	as	usual		
In	recent	weeks,	a	number	of	US	Senators	have	been	criticized	for	selling	stocks	just	before	most	had
been	able	to	realize	the	seriousness	of	the	threat	posed	by	Covid-19.	Lauren	C.	Bell	writes	that	US
politicians	have	a	long	history	of	stock	trading	in	ethically	murky	circumstances,	and	that	Congress’
recent	efforts	to	address	this	problem	with	legislation	does	not	go	far	enough.
In	mid-March,	as	the	US	was	first	beginning	to	realize	just	how	dangerous	the	novel	coronavirus	really
was,	ProPublica	reported	that	one-month	prior,	Senate	Intelligence	Committee	Chairman	Richard	Burr	(R-NC)	sold
off	stocks	worth	up	to	$1.7	million	just	as	his	committee	was	receiving	daily	intelligence	briefings	on	the	threat	of
Covid-19.	At	almost	the	same	time,	The	Daily	Beast	revealed	that	Senator	Kelly	Loeffler	(R-GA)	—who	happens	to
be	married	to	the	chair	and	chief	executive	officer	of	the	New	York	Stock	Exchange—also	sold	multiple	stocks	on
the	same	day	that	the	Senate	Health	Committee,	on	which	she	sits,	held	an	all-day	briefing	by	administration
officials	on	the	coronavirus.
There	were	other	senators,	including	Democrat	Dianne	Feinstein	(CA)	and	Republicans	James	Inhofe	(OK)	and
Ron	Johnson	(WI),	whose	financial	disclosures	to	the	Senate	Ethics	Committee	indicated	that	they,	too,	sold	stocks
in	the	weeks	leading	up	to	the	COVID-19	outbreak	in	the	US,	but	their	sales	were	less	obviously	connected	to
information	they	received	in	their	roles	as	US	Senators	and	were	more	plausibly	explained	by	other	evidence.
The	US	Department	of	Justice	announced	at	the	end	of	March	that	it	was	opening	an	investigation	into	lawmakers’
stock	transactions;	so	far,	Burr	appears	to	be	in	the	most	hot	water.
Accusations	that	members	of	Congress	have	profited	from	knowledge	they	acquired	in	their	official	capacities	are
nothing	new.	Charles	Guisst,	in	his	1997	book	Wall	Street:	A	History	from	Its	Beginnings	to	the	Fall	of	Enron,	writes
that	in	“[t]he	period	prior	to	the	Civil	War	saw”	Whig/Oppositionist	Congressman	Russell	Sage	(NY)	“engaged	in
many	railroad	deals,	usually	using	his	insider’s	knowledge	gained	in	Congress	to	move	in	on	deals	at	the
appropriate	time.”	The	Congressional	Misconduct	Database	identifies	three	members	of	Congress	who	were
ensnared	in	the	1873	Crédit	Mobilier	Scandal,	which	involved	the	sale	of,	and	profit	from,	cut-rate	shares	of	stock	in
a	fraudulent	construction	company	created	by	Union	Pacific	Railroad	to	bribe	government	officials.
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More	recently,	it	was	noted	in	the	Journal	of	Business	and	Securities	Law	that	in	2005,	Tennessee	senator	and
future	US	Senate	Majority	Leader	Bill	Frist	sold	his	holdings	in	Hospital	Corporation	of	America	(HCA),	a	company
his	family	founded,	just	days	before	the	stock	price	dropped	substantially	over	a	period	of	successive	weeks.
Former	House	Financial	Services	Committee	Ranking	Member	Spencer	Bachus	was	accused	of	insider	trading
when	he	made	a	series	of	stock	moves	throughout	the	summer	of	2008.	Both	Barack	Obama	and	Hillary	Clinton
were	briefly	investigated,	at	least	by	the	media,	in	the	mid-2000s	for	potential	ethics	violations	related	to	the	stock
market.	In	2019,	Representative	Chris	Collins	(R-NY)	was	investigated	for,	and	later	convicted	of,	insider	trading
violations.
Despite	multiple	examples	of	members	of	Congress	benefitting,	or	appearing	to	benefit,	from	information	they
obtained	in	the	course	of	their	regular	duties,	for	several	decades	leading	up	to	congressional	action	in	2012,	the
conventional	wisdom	was	that	insider	trading	laws	did	not	apply	to	Congress.	According	to	Sung	Hui	Kim,	writing	in
the	Cornell	Law	Review	in	2013,	this	was	because	members	of	Congress	were	thought	to	be	immune	from	federal
laws	prohibiting	insider	trading.	Insider-trading	laws	required	a	breach	of	fiduciary	responsibility,	and	members	of
Congress,	simply	put,	were	thought	to	have	no	fiduciary	duty	to	anyone.
In	2012,	Congress	passed	the	STOCK	(Stop	Trading	on	Congressional	Knowledge)	Act	to	“prohibit	Members	of
Congress	and	employees	of	Congress	from	using	nonpublic	information	derived	from	their	official	positions	for
personal	benefit,	and	for	other	purposes.”	Versions	of	this	act	had	been	introduced	as	early	as	2006,	but	it	was	not
until	2012	that	the	Act	was	signed	into	law.	(At	the	time	the	STOCK	Act	was	passed,	McClatchy	News	reported	that
Senator	Burr	was	one	of	only	three	senators	to	vote	no	on	the	bill.)	In	addition	to	banning	the	use	of	non-public
information	for	private	gain,	including	by	members	of	Congress,	the	Act	shortened	stock	sales’	reporting	timelines
from	within	a	year	to	within	45	days—which	is	how	we	learned	so	quickly	about	the	Burr	and	Loeffler	sales.
The	STOCK	Act	made	it	explicitly	illegal	for	members	of	Congress	to	profit	from	classified	or	other	private
information	they	received	in	the	course	of	doing	their	jobs.	And	it	seemed	to	work:	in	a	December	2019	editorial	in
the	New	York	Times,	citing	a	2017	study	by	Public	Citizen,	the	editorial	board	wrote:	“The	volume	of	stock	trading
by	members	of	Congress	declined	by	65	percent	in	the	three	years	after[the	STOCK	Act]	took	effect,	compared	with
the	three	years	before	its	passage.”
Still,	making	congressional	insider	trading	illegal	is	the	easy	part.	Proving	that	members	committed	a	violation	of	the
STOCK	Act	and	attendant	federal	law	remains	difficult.	Moreover,	many	political	observers	believe	that	the	Act	does
not	go	far	enough.	Members	are	not	required	to	put	their	assets	in	a	blind	trust,	nor	are	they	required	to	forego
continued	trading	or	earning	profits	on	existing	stocks.	In	May	2019,	US	Senators	Jeff	Merkley	(D-OR)	and	Sherrod
Brown	(D-OH)	introduced	legislation	to	strengthen	legal	and	ethical	prohibitions	on	members	profiting	from	stock
holdings.	The	legislation	was	already	unlikely	to	gain	much	traction	in	the	legislative	graveyard	that	the	Senate	has
become	in	recent	years.	Now,	with	Congress	facing	a	global	pandemic,	an	economy	turned	upside	down	nearly
overnight,	and	an	upcoming	presidential	election,	the	prospects	for	swift	legislative	action	to	strengthen	or	enhance
restrictions	on	member	profiteering	are	unlikely	any	time	soon.
Congress’s	approval	ratings	have	been	deeply	underwater	for	decades;	the	recent	revelations	of	possible	insider
trading	on	the	part	of	a	handful	of	members	will	further	entrench	the	view	among	a	large	swath	of	the	American
public	that	members	of	Congress	seek	to	enrich	themselves	at	the	expense	of	their	constituents	and	the	country.
With	the	US	facing	urgent	public	health	and	economic	crises,	this	further	erosion	of	public	confidence	could	not	be
coming	at	a	worse	time.
Please	read	our	comments	policy	before	commenting.					
Note:	This	article	gives	the	views	of	the	author,	and	not	the	position	of	USAPP	–	American	Politics	and	Policy,	nor
the	London	School	of	Economics.
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